Shares of Cogent Biosciences surged in 2025 as enthusiasm mounted over its lead drug candidate, and four top-ranking ...

As of Wednesday, January 07, Regencell Bioscience Holdings Limited’s RGC share price has surged by 20.07%, which has investors questioning if this is right time to sell.

Investing.com -- Ventyx Biosciences (NASDAQ:VTYX) stock surged 5% and was halted for volatility following reports that Eli Lilly (NYSE:LLY) is in advanced talks to acquire the biotech company for more ...

Niagen Bioscience continues to see improving demand for Tru Niagen, strengthening cash generation, and a debt-free balance ...

Fintel reports that on January 8, 2026, Morgan Stanley downgraded their outlook for Neurocrine Biosciences (NasdaqGS:NBIX) ...

Shares of Pacira BioSciences slipped after the company's preliminary-revenue report came in below Wall Street estimates. The stock fell 9.7%, to $23.49, in after-hours trading Thursday. Through the ...

Cemtrex completed its acquisition of a Texas military engineering firm. Shares gained 35.5% to $3.94 in after-hours trading Thursday. Olin cut its fourth-quarter outlook, citing a slowdown in ...

Investing.com -- Coherus BioSciences Inc (NASDAQ:CHRS) stock rose 5.8% on Monday following the publication of research supporting the potential of its investigational cancer treatment tagmokitug.

NovaBridge stock was trading higher Tuesday but has since reversed and begun trading lower. NovaBridge announced upgrade results from the Phase 1b combination study of givastomig.

Precision BioSciences offers high-risk, high-reward potential, trading below cash with key HBV and DMD data catalysts ...

Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) ('Bright Minds” or the 'Company”) announces the pricing of its ...

Ventyx Biosciences shares rose 29% after The Wall Street Journal reported that the company is in advanced talks to be ...